Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system
Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system
复制标题
DOI:
10.1093/ajhp/zxy083
复制
发表时间:
2019-04-01
影响因子:
2.7
通讯作者:
Gionfriddo, Michael R.
中科院分区:
文献类型:
--
作者:
Jones, Laney K.;Ladd, Ilene G.;Gionfriddo, Michael R.
Purpose. The barriers and solutions to the current prior-authorization (PA) process at an integrated health system were evaluated.Methods. Focus groups were conducted with patients at an integrated health system who also had insurance from an affiliated health plan and at least 1 denial for a medication in the past year. Semistructured interviews were conducted with medical staff (physicians, office staff, and PA experts). Both focus groups and interviews were audio-recorded and transcribed. Inductive analysis was used to code transcripts and develop themes.Results. Three focus groups were conducted with 13 patients, and 9 medical staff (3 staff physicians, 2 office staff, and 4 PA staff) who have interactions with the PA process interviewed. Several themes were identified including the complexity of the PA process, consequences experienced, and ineffective communication between key stakeholders. A cross-cutting theme was that stakeholders expressed feelings of frustration, anxiety, and anger throughout the PA process. All stakeholders offered insights on how the process could be improved to better facilitate their preferences, such as access to the list of medications that require PA and the need for a patient advocate.Conclusion. Results of this study revealed that the PA process was frustrating, upsetting, and infuriating to patients and medical staff involved in the process. Three main themes identified included the complexity of the PA process, consequences experienced from the PA process, and ineffective communication between stakeholders.